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Environmental exposure to particulate matter
(PM) has been associated with increased car-
diovascular mortality in the elderly (Aga et al.
2003; Devlin et al. 2003; Samet et al. 2000)
and reductions in heart rate variability (HRV),
a measure of cardiac autonomic regulation
(Gold et al. 2000; Holguin et al. 2003; Park
et al. 2005). Although not well understood,
the mechanisms of PM-induced health effects
are believed to involve inflammation and
oxidative stress initiated by the formation of
reactive oxygen species (ROS) within affected
cells (Cho et al. 2005; Gonzalez-Flecha 2004).
In vitro studies have shown that inhaled PM
causes expression of nuclear factor kappa-B
(NF-κB)-related genes and oxidant-dependent
NF-κB activation (Jimenez et al. 2000; Shukla
et al. 2000). To defend against the oxidative
damage, cells use up their stores of a key
antioxidant, glutathione; glutathione depletion
can induce a state of cellular stress and the acti-
vation of additional intracellular signaling cas-
cades that regulate the expression of cytokine
and chemokine genes and widespread proin-
flammatory effects remote from the site of
damage (Saxon and Diaz-Sanchez 2005). Data
from PM samples of 20 European cities have
shown that PM with an aerodynamic diameter
≤ 2.5 μm (PM2.5) has strong redox activity and
is able to deplete artificial respiratory lining
ﬂuid of reduced glutathione (GSH) and ascor-
bate (Künzli et al. 2006). PM, depending on
its toxicity, seems also to inhibit protective
enzymes involved in oxidative stress responses
[copper/zinc (Cu/Zn) superoxide dismutase
(SOD), manganese SOD, glutathione peroxi-
dase (GSH-Px), and glutathione reductase]
(Hatzis et al. 2006). Alteration of autonomic
function related to PM2.5 exposure appears to
be partly associated with oxidative stress
(Brook et al. 2003; Chahine et al. 2007).
Increased intake of omega-3 polyunsatu-
rated fatty acids (n-3 PUFA) has been shown
to decrease the risk of cardiovascular events
(GISSI Prevenzione Investigators 1999; Kris-
Etherton et al. 2002; Leaf et al. 2003). The
protective effect of n-3 PUFA seems to be
linked in part to its cardiac antiarrhythmic
properties (Christensen et al. 2001; Holguin
et al. 2005; Kris-Etherton et al. 2002; Leaf
2001) and its anti-inflammatory effects
(Calder 2006). Long-chain n-3 PUFA
appears to act both directly (by replacing
arachidonic acid as an eicosanoid substrate
and inhibiting arachidonic acid metabolism)
and indirectly by altering the expression of
inflammatory genes through effects on tran-
scription factor activation (Calder 2006). Fish
oil has been shown to modulate endothelial
activation possibly by reducing ROS and
therefore leading to the subsequent inactiva-
tion of the NF-κB system of gene transcrip-
tion. This role of oxygen scavenging would
lead to the prevention of O2-generating
hydrogen peroxide (H2O2) and thus prevent
cell activation (De Caterina et al. 2000).
We have previously shown that exposure
to PM2.5 is related to a decrease in HRV in
elderly residents of a nursing home in Mexico
City (Holguin et al. 2003) and that fish oil
supplementation could increase HRV
(Holguin et al. 2005) and modulate the
adverse effects of PM2.5 on HRV (Romieu
et al. 2005). We hypothesized that one of the
mechanisms by which ﬁsh oil and, to a lesser
extent, soy oil supplementation would modu-
late the adverse effects of PM2.5 on HRV
would be by acting on the oxidative stress
response, reducing the generation of ROS,
modulating the use of GSH as part of the
oxidative stress response, and increasing the
activity of enzymes involved in response to
oxidative stimuli. We tested this hypothesis in
a randomized trial of fish oil versus soy oil
supplementation to prevent reductions in car-
diac autonomic function associated with PM
exposure. During the trial, we measured
Cu/Zn SOD activity, GSH, and LPO levels
in plasma to evaluate the impact of fish oil
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BACKGROUND: The mechanisms of particulate matter (PM)-induced health effects are believed to
involve inﬂammation and oxidative stress. Increased intake of omega-3 polyunsaturated fatty acids
(n-3 PUFA) appears to have anti-inﬂammatory effects. 
OBJECTIVE: As part of a trial to evaluate whether n-3 PUFA supplementation could protect against
the cardiac alterations linked to PM exposure, we measured biomarkers of response to oxidative
stimuli [copper/zinc (Cu/Zn) superoxide dismutase (SOD) activity, lipoperoxidation (LPO) prod-
ucts, and reduced glutathione (GSH)] and evaluated the impact of supplementation on plasma levels. 
METHODS: We recruited residents from a nursing home in Mexico City chronically exposed to PM
≤ 2.5 µm in aerodynamic diameter (PM2.5) and followed them from 26 September 2001 to 10
April 2002. We randomly assigned subjects in a double-blind fashion to receive either ﬁsh oil (n-3
PUFA) or soy oil. We measured PM2.5 levels indoors at the nursing home, and measured Cu/Zn
SOD activity, LPO products, and GSH at different times during presupplementation and supple-
mentation phases. 
RESULTS: Supplementation with either fish or soy oil was related to an increase of Cu/Zn SOD
activity and an increase in GSH plasma levels, whereas exposure to indoor PM2.5 levels was related
to a decrease in Cu/Zn SOD activity and GSH plasma levels. 
CONCLUSION: Supplementation with n-3 PUFA appeared to modulate the adverse effects of PM2.5
on these biomarkers, particularly in the fish oil group. Supplementation with n-3 PUFA could
modulate oxidative response to PM2.5 exposure.
KEY WORDS: biological markers, omega-3 polyunsaturated fatty acids (PUFA), oxidative stress,
PM2.5. Environ Health Perspect 116:1237–1242 (2008). doi:10.1289/ehp.10578 available via
http://dx.doi.org/ [Online 16 May 2008]and soy oil supplementation and exposure to
PM2.5 on these biomarkers.
Materials and Methods
Study population and design. We recruited
residents from a nursing home in Mexico City
who were chronically exposed to PM2.5 and
followed them from 26 September 2001 to
10 April 2002. We randomly assigned sub-
jects in a double-blind fashion to receive
either ﬁsh oil (n-3 PUFA) or soy oil. We con-
ducted the study in two phases: a presupple-
mentation phase of 3 months (27 September
to 17 December 2001) and a supplementation
phase of 4 months (9 January to 5 April 2002)
(Holguin et al. 2005). Before starting supple-
mentation, participants provided a blood sam-
ple. During the supplementation phase, we
asked subjects to provide three blood samples
at 1 month, 3 months, and at the end of the
study; seven participants provided only two
samples during the supplementation phase. In
addition, we measured indoor and ambient
PM2.5 levels in the nursing home, and each
participant kept a diary of daily activities. 
The eligibility criteria were age > 60 years,
absence of cardiac arrhythmias, no cardiac
pacemaker, no allergies to n-3 PUFA or ﬁsh,
no treatment with oral anticoagulants, no his-
tory of bleeding diathesis, and ability to
undergo HRV measurements in the supine
position. Among 63 residents invited to the
study, 52 agreed to participate and provided
written informed consent for both random-
ization and supplementation (for study
design, see Figure 1). At baseline, all partici-
pants answered to a general purpose question-
naire and a validated food frequency
questionnaire administered by a nutritionist
(Hernandez-Avila et al. 1998; Romieu et al.
1999). We extracted past medical histories
from the medical ﬁles. The trial protocol was
approved by the Institutional Research Board
and Ethical Committee of the National
Institute of Public Health in Mexico.
Randomization to n-3 fish oil or soy oil.
We randomly assigned participants to two
groups at baseline using a random-number
table. Compliance was determined by directly
observed supplement intake. Patients in the
fish oil group received 2 g/day in divided
doses. Each capsule contained 83.2% n-3
PUFA [52.4% docosahexanoic acid (C22:6
n-3 DHA), 25.0% eicosopentanoic acid
(C20:5 n-3 EPA) and 5.8% docosapentaenoic
acid (c22:5n-3 DPA)]. The soy oil capsules
were identical, and each capsule contained
6.78% α-linolenic acid (ALA), a plant n-3
PUFA (C18:3 n-3), 16.3% saturated fat,
52.7% linoleic acid (C18:2 n-6), and 22.5%
oleic acid (C18:1 n-9). Neither the partici-
pants nor the study personal were aware of the
randomization group.
Pollutants and temperature measurements.
We determined daily 24-hr measurements of
PM2.5 by gravimetric analysis using Mini-Vol
portable air samplers (version 4.2; Air Metrics,
Eugene, OR, USA), with 47 mm Teﬂon ﬁlters
(Pall Gelman Laboratory, Ann Arbor, MI,
USA) and ﬂows set at 4 L/min, located within
the living room of the nursing home during
the follow-up period. Filter gravimetric analysis
was performed at the air laboratory of the
National Center for Environmental Research
and Training in Mexico City under controlled
climatic and temperature conditions. Filter
weights were obtained by a micrometric scale
(Cahn C-35; Thermo Electron Corp., Round
Rock, TX, USA) under laminar ﬂow.
We obtained ambient levels of ozone,
nitrogen dioxide, sulfur dioxide, and carbon
monoxide as well as climatic variables from an
automated monitoring station located 3 km
upwind from the study site (in Tacuba, to the
northeast). Given the low concentrations
observed for SO2, NO2, and CO, we excluded
these pollutants from further analysis.
Laboratory analysis. We immediately cen-
trifuged blood samples, protected plasma
aliquots with aluminum foil, and stored them
at –70°C until analysis. Laboratory measure-
ments were conducted in duplicate at the lab-
oratory of the National Institute of Neurology
in Mexico City. We used the mean of the
duplicate measurements as the biomarker val-
ues for each individual at each sampling time.
Cu/Zn SOD activity. We assayed SOD
activity by the xanthine/xanthine oxidase
method as modiﬁed by Alcaraz-Zubeldia et al.
(2001) from the method described by
Schwartz et al. (1998). We diluted plasma
samples in a buffer consisting of 20 mM
sodium bicarbonate and 0.02% Triton X-100
(pH 10.2), centrifuged them at 4,000 × g for
10 min, and collected the supernatants. We
then added 50 μL of the clariﬁed supernatant
to 950 μL of the reaction mixture consisting of
10 μM sodium azide, 100 μM xanthine,
10 μM reduced cytochrome c, and 1 mM
EDTA in 20 mM sodium bicarbonate, 0.02%
Triton X-100 (pH 10.2). We initiated the
assay by adding xanthine oxidase and moni-
tored it by measuring the change in absorbance
at 560 nm in a Lambda-20 ultraviolet/visible
spectrophotometer (Perkin Elmer, Waltham,
MA, USA). We carried out the analysis of sam-
ples in duplicate and calculated the participa-
tion of each SOD type as total activity minus
the activity inhibited by the addition of 5 mM
sodium cyanide, because cyanide selectively
inhibits the Cu/Zn SOD isoform. The results
are expressed as international units per milli-
liter. Measurements of Cu/Zn SOD were
available for 20 subjects assigned to the soy oil
group and 24 subjects assigned to the ﬁsh oil
group. The coefﬁcient of variation (mean) of
duplicate measurements was 1.6%.
LPO in plasma. We monitored lipid ﬂuo-
rescence product formation as an index of
LPO in plasma samples using the method
described by Triggs and Willmore (1984). We
separated 500 μL of each plasma sample into a
glass tube, covered from light, and added
4 mL of a chloroform-methanol 2:1 mixture.
We measured ﬂuorescence in a Perkin Elmer
LS50B luminescence spectrophotometer at
370 nm excitation and 430 nm emission. We
adjusted sensitivity of the spectrophotometer
to 140 fluorescence units with a 0.1-mg/L
quinine standard, prepared in 0.05 M aqueous
sulfuric acid solution, before the measurement
of the samples. We used pooled plasma sam-
ples obtained from healthy controls as an
internal quality control. We obtained refer-
ence values for pooled plasma samples from
repeated analyses to obtain quality control
charts. Each time we carried out the measure-
ments, we determined the pooled samples in
the same sample batch to assess the repro-
ducibility of the measurements. Results are
expressed as ﬂuorescence units (FU) per milli-
liter. We ran all samples in duplicate.
Measurements of LPO products were available
for 21 subjects assigned to the soy oil group
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Figure 1. Study design.
Time (2001–2002)
Oct Nov Dec Jan Feb March April
Study group
(n = 52)
Randomization
Presupplementation
27 Sep–17 Dec
Supplementation
9 Jan–5 April
Fish oil group (n = 26)
Soy oil group (n = 26)
Baseline
blood sample
Blood samplesand 21 subjects assigned to the ﬁsh oil group.
The coefficient of variation (mean) of the
duplicate measurements was 10.9%.
GSH levels in plasma. We assayed GSH
using the method described by Hu (1994).
We diluted plasma samples 1:1 with a 10%
(wt/vol) trichloroacetic solution and placed
tubes on ice for 10 min. We measured ﬂuores-
cence in a Perkin Elmer LS50B luminescence
spectrophotometer at 350 nm excitation and
420 nm emission. For blank sample analysis,
we substituted plasma samples with deionized
water and treated these as regular samples.
We performed internal quality control for
GSH measurements as described for the lipid
fluorescence product assay. We constructed
calibration curves for glutathione and
obtained the concentrations by interpolation
in the standard curve. We express our results
as micromolar concentrations of GSH.
Measurements of GSH were available for 20
subjects assigned to the soy oil group and
23 subjects assigned to the ﬁsh oil group. The
coefficient of variation (mean) of the dupli-
cate measurements was 1.8%.
Statistical analysis. We compared the
mean Cu/Zn SOD activity, LPO products,
and GSH levels in plasma at baseline between
the soy oil and the ﬁsh oil groups using a t-test.
To normalize the distribution, we square-
root–transformed the measure of LPO and
log-transformed GSH. We determined the
effect of supplementation by soil oil and ﬁsh
oil and of PM2.5 exposure on Cu/Zn SOD
activity, LPO products, and GSH levels in
plasma using linear mixed models (Xu and
Hedeker 2001) treating patient as random
effect. Linear mixed models account for
repeated measurements within the same indi-
vidual and allow for variation of effect among
individuals. We assigned the same-day indoor
PM2.5 level measured (24-hr average) in the
nursing home area as PM2.5 exposure for sub-
jects tested on a given day (12 subjects/day).
We adjusted regression models only for time,
because characteristics of the general popula-
tion were equally distributed between groups
and did not confound the association. We also
tested for interaction between PM2.5 levels and
supplementation phase for both the soy and
ﬁsh oil supplementation groups.
We assessed the possible nonlinearity of
PM2.5 using generalized additive mixed mod-
els (GAMM) with p-splines (Greven et al.
2006; Hastie and Tibshirani 1990), modeling
the dose–response relationship between bio-
markers of response to oxidative stimuli and
pollutant as a smooth function. Because we
observed nonlinear associations between
PM2.5 and these biomarkers in the fish oil
group, we included a quadratic term of PM2.5
in our mixed linear model. We assigned the
same-day indoor PM2.5 level measured in the
nursing home area as PM2.5 exposure for
subjects tested on a given day (12 subjects per
day). We used the chi-square or Fisher’s exact
test for discrete variables and frequencies, and
considered a p-value of < 0.05 signiﬁcant. We
conducted statistical analyses using Stata 8.2
(StataCorp., College Station, TX, USA) and
GAMM using a SAS macro (version 9.1; SAS
Institute Inc., Cary, NC, USA).
Results
Study sample. Table 1 presents the general
characteristics of participants according to
their assignment to either the fish oil or soy
oil supplementation groups. Most of the gen-
eral characteristics were similar between
groups. Ischemic cardiac disease was more fre-
quent in the ﬁsh oil group (n = 0 vs. n = 4),
and body mass index (BMI) was slightly
lower in the fish oil group (27.6 vs. 24.6).
Only three participants in the fish oil group
and three in the soy oil group reported smok-
ing outside of the residential home (Table 1).
At baseline, participants from both the ﬁsh oil
and soy oil groups reported low dietary
intakes of foods rich in n-3 PUFA.
Environmental exposure data. Participants
in both groups spent on average 93% of their
time indoors. The mean daily PM2.5 ambient
level in the living room of the residence was
38.7 μg/m3 (14.7 SD), the median was 35.11
μg/m3, and the 25th and 75th percentiles were
30.62 μg/m3 and 41.10 μg/m3, respectively
(range, 14.8–70.9 μg/m3). Indoor and outdoor
PM2.5 measurements were highly correlated (r
= 0.95). We obtained O3, PM10 outdoor levels,
and climatic data from the closest monitoring
station. During the study phase, the O3 1-hr
maximum ranged from 11.6 to 57.5 ppb, and
the PM10 24-hr average ranged from 39.5 to
109.9 μg/m3.
Fatty acids in erythrocytes. In this study, we
were not able to measure erythrocyte n-3 PUFA
levels. However, a study conducted in a similar
population with the same dose of ﬁsh and soy
oil showed an important increase of EPA
(eicosopentanoic acid) and DHA (docosahexa-
noic acid) in the ﬁsh oil group after 5 months
of supplementation (394% and 140%, respec-
tively), and a moderate increase in EPA (87%)
and no signiﬁcant changes in DHA in the soy
oil group; EPA and DHA were significantly
higher in the ﬁsh oil group (p < 0.01) (Romieu
et al. 2005) [Supplemental Material, Table 1
(online at http://www.ehponline.org/members/
2008/10578/suppl.pdf)].
Biomarkers of responses to oxidative stim-
uli. Characteristics of subjects who provided
blood samples in the two phases of the study
(presupplementation and supplementation
phases) (n = 45) and those who did not (n = 7)
were similar. At baseline (presupplementation
phase), Cu/Zn SOD activity, LPO products,
and GSH levels in plasma were similar in both
supplementation groups (Table 1).
We first modeled the data from partici-
pants in both supplementation groups and
evaluated the impact of supplementation and
exposure to PM2.5 on these biomarkers
(Table 2). Supplementation significantly
increased the Cu/Zn SOD activity (β = 0.27,
p = 0.002), significantly decreased levels of
LPO products (β = –4.52, p = 0.03), and sig-
nificantly increased levels of GSH in plasma
(β = 0.95, p < 0.001). Indoor PM2.5 levels
were inversely related to Cu/Zn SOD activity
(β = –0.05, p = 0.001). The relation between
GSH and PM2.5 levels was nonlinear (sig-
nificant quadratic term for PM2.5 levels)
(Table 2).
We further stratiﬁed data by supplemen-
tation group (Table 3). As observed in the
overall analysis of both supplementation
groups, supplementation appeared to have a
protective effect in the ﬁsh oil group (signiﬁ-
cant positive association with Cu/Zn SOD
activity, β = 0.29, p = 0.04; inverse association
with LPO products, β = –3.72, p = 0.002;
positive association with GSH levels, β = 1.0,
Omega-3 PUFA, oxidative stress, and PM2.5
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Table 1. Characteristics of the study population at baseline.
Soy oil (n = 26) Fish oil (n = 26)  p-Value
Age [mean (range)] 77 (60–88) 76 (60–96) 0.491
Male sex [no. (%)]  12 (46.2) 12 (46.2) 1.000
Smokers [no. (%)] 3 (11.5) 3 (11.5) 1.000
Medical conditions [no. (%)]
Diabetes 2 (7.7) 6 (23.1) 0.124
Hypertension 8 (34.6) 10 (38.5) 0.773
Ischemic cardiac disease 0 (0.0) 4 (15.4) 0.037
COPD  2 (7.7) 3 (11.5) 0.638
Medical treatment [no. (%)]
β-Blockers 1 (3.9) 2 (7.7) 0.552
Angiotensin-converting enzyme inhibitors 2 (7.7) 3 (11.5) 0.638
Calcium-channel blockers 3 (11.5) 2 (7.7) 0.638
Diuretics 0 (0.0) 3 (11.5) 0.298
BMI [mean (range)] 27.6 (20.1–37.2) 24.6 (16.6–35.9) 0.023
Oxidative stress biomarkersa (mean ± SD)
Cu/Zn SOD (IU/mL) 0.76 ± 0.04 0.68 ± 0.05 0.22
LPO (FU/mL) 18.62 ± 9.88 19.08 ± 7.90 0.85
GSH (µM) 3.66 ± 1.39 4.38 ± 1.70 0.31
aReference values: Cu/Zn SOD, ≥ 0.75 IU/mL; LPO, 25.76–32.08 FU/mL; GSH, ≥ 5 µM.p < 0.001); in the soy oil group, supplementa-
tion was positively related to Cu/Zn SOD
activity (β = 0.17, p = 0.05) and GSH levels
(β = 0.70, p = 0.003). We observed no effect
of soy oil supplementation on LPO products
(Table 3). Based on models presented in Table
3, we calculated that, compared with baseline,
supplementation with fish oil led to an
approximate increase in Cu/Zn SOD activity
of 49.1% [95% confidence interval (CI),
2.4–81.5] and in GSH levels of 62% (95%
CI, 43.3–89.0%), and an approximate
decrease in LPO products of 72.5% (95% CI,
15–172%). For the soy oil group, we calcu-
lated an increase of 22.6% (95% CI,
0.7–44.0%) in Cu/Zn SOD activity and of
55.3% (95% CI, 36.3–85.1%) in GSH levels
compared with baseline.
PM2.5 levels were inversely related to
Cu/Zn SOD activity in the soy oil group (β =
–0.06, p < 0.001) (Table 3). In the fish oil
group, the relations between these biomarkers
of response to oxidative stimuli and PM2.5
levels were nonlinear. Both a linear term and
a quadratic term for PM2.5 levels were signiﬁ-
cant predictors of these biomarkers (Table 3).
To better evaluate the shape of the associa-
tion between PM2.5 levels and the biomarkers
of interest, we used GAM models. In the soy
oil group, we observed that Cu/Zn SOD
activity decreased linearly with increased lev-
els of PM2.5. We observed no significant
effect on LPO products and GSH levels
(Figure 2A–C); in the fish oil group, we
observed that Cu/Zn SOD activity tended to
decrease with exposure to PM2.5 until levels
came close to 40–45 μg/m3, and then the
effect leveled off (Figure 3A). LPO products
tended to decrease at low levels of PM2.5 and
start increasing after PM2.5 levels of 40–45
μg/m3 (Figure 3B). For GSH levels, we
observed little change until around 40 μg/m3
PM2.5, after which we observed a significant
decrease (Figure 3C). However, because
almost 75% of our PM2.5 measurements were
< 45 μg/m3, our estimates at higher PM2.5
levels derive from sparse data.
Discussion
In this randomized controlled trial, we
observed that supplementation with both soy
oil and fish oil appeared to modulate the
plasma levels of biomarkers of response to
oxidative stimuli by increasing Cu/Zn SOD
activity and GSH levels. In addition, ﬁsh oil
supplementation reduced LPO products in
plasma. Fish oil appeared to modulate the
adverse effect of PM2.5 in a nonlinear manner.
This is the first study to evaluate the
impact of supplementation with n-3 PUFA
on biomarkers of response to oxidative stimuli
related to air pollution exposure among indi-
viduals in a noncontrolled environment. The
mechanisms of PM-induced health effects are
believed to involve inflammation and oxida-
tive stress. The oxidative stress mediated by
PM may arise from direct generation of ROS
or be related to altered function of mitochon-
dria or NADPH-oxidase (nicotinamide ade-
nine dinucleotide phosphate-oxidase) and
activation of inflammatory cells capable of
generating ROS, reactive nitrogen species,
and oxidative DNA damage (Gonzalez-Flecha
2004; Risom et al. 2005). In vitro studies
have shown that PM exposure increases the
expression of NF-κB–related genes and acti-
vation of oxidant-dependent NF-κB factors,
such as tumor necrosis factor-α, and inter-
leukin-8 and -6 (Gonzalez-Flecha 2004;
Jimenez et al. 2000; Risom et al. 2005;
Shukla et al. 2000). In animal experiments,
airborne PM2.5 have been shown to increase
levels of LPO and alter intracellular redox sta-
tus in multiple organs with decreased SOD,
catalase, and GSH-Px activities and depleted
GSH levels (Liu and Meng 2005). Transgenic
mice with overexpression of extracellular
SOD (EC-SOD) had lower concentrations of
oxidized glutathione in the lung after expo-
sure to residual oily ﬂy ash (ROFA), suggest-
ing that enhanced EC-SOD expression
decreased both lung inﬂammation and dam-
age after exposure to ROFA (Ghio et al.
2002). A recent enzyme activity assay showed
that the activity of Cu/Zn SOD is reduced by
PM, particularly ROFA and urban PM
(Hatzis et al. 2006). The impact of PM2.5
observed in our study is in line with those
results. This impairment of defense against
oxidative stress could be responsible for the
decrease in HRV observed in the elderly
because alteration of autonomic function
related to PM2.5 exposure appears to be partly
associated with oxidative stress (Brook et al.
2003; Chahine et al. 2007).
The major source of PM2.5 in Mexico
City is related to vehicular trafﬁc, and a large
proportion of vehicles use diesel fuel
(Secretaría de Medio Ambiente y Recursos
Naturales 2003; Secretaría de Transporte y
Vialidad 2006). Because smoking was not
allowed in the nursing home, the main source
of PM2.5 measured indoors came from out-
door sources, with a correlation of r = 0.95
between indoor and outdoor PM2.5 levels.
Supplementation by both ﬁsh oil contain-
ing EPA and DHA (83.2%/g) and soy oil
containing ALA (6.7%), a plant-derived n-3
PUFA, appears to enhance the response to
oxidative stress by increasing Cu/Zn SOD
Romieu et al.
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Table 3. Effects of PM2.5 exposure on biomarkers of oxidative stress by supplementation groups.
Soy oil Fish oil
β (SE) p-Value β (SE) p-Value
Cu/Zn SOD
Intercept 0.75 (0.03) < 0.001 0.60 (0.06) < 0.001
Supplementationa 0.17 (0.09) 0.050 0.29 (0.14) 0.042
Indoor PM2.5 –0.06 (0.02) < 0.001 –0.17 (0.05) 0.002
Indoor (PM2.5)2b — 0.04 (0.02) 0.009
LPOc
Intercept 4.15 (0.23) < 0.001 3.96 (0.21) < 0.001
Supplementationa 0.49 (1.13) 0.669 –3.72 (1.04) 0.002
Indoor PM2.5 –0.02 (0.14) 0.904 –0.35 (0.19) 0.080
Indoor (PM2.5)2 — 0.16 (0.07) 0.024
GSHd
Intercept 1.21 (0.10) < 0.001 1.44 (0.08) < 0.001
Supplementationa 0.70 (0.22) 0.003 1.00 (0.19) < 0.001
Indoor PM2.5 –0.03 (0.04) 0.406 –0.09 (0.04) 0.017
Data are regression coefficients; we adjusted models for date. For PM2.5, the coefficients correspond to a change in
10 µg/m3. Regression models for Cu/Zn SOD include 20 subjects and 74 observations in the soy oil group and 24 subjects
and 90 observations in the ﬁsh oil group; for LPO, 21 subjects and 51 observations in the soy oil group and 21 subjects and
55 observations in the ﬁsh oil group; for GSH, 20 subjects and 76 observations in the soy oil group and 23 subjects and
86 observations in the ﬁsh oil group.
aReference category: presupplementation. bLinear relationship; indoor (PM2.5)2 does not apply. cSquare root transformed.
dLog transformed.
Table 2. Effects of supplementation and exposure to PM2.5 on biomarkers of oxidative stress.
Cu/Zn SOD LPOa GSHb
β (SE) p-Value β (SE) p-Value β (SE) p-Value
Intercept 0.73 (0.04) < 0.001 4.54 (0.52) < 0.001 1.32 (0.08) < 0.001
Supplementationc 0.27 (0.08) 0.002 –4.52 (2.00) 0.029 0.95 (0.14) < 0.001
Fish oild –0.04 (0.04) 0.245 0.03 (0.19) 0.897 0.10 (0.09) 0.274
Indoor PM2.5 –0.05 (0.02) 0.001 0.08 (0.09) 0.381 0.06 (0.05) 0.176
Indoor (PM2.5)2e — — –0.05 (0.01) 0.002
Data are regression coefficients; we adjusted models for date. For PM2.5, the coefficients correspond to a change in
10 µg/m3. The regression model for Cu/Zn SOD includes 44 subjects and 164 observations; for LPO, 42 subjects and
106 observations; for GSH, 43 subjects and 162 observations.
aSquare root transformed. bLog transformed. cReference category: presupplementation. dReference category: soy oil.
eLinear relationship; indoor (PM2.5)2 does not apply.activity and GSH. The antioxidant enzyme
Cu/Zn SOD appears to play an important
role in response to oxidative stress, catalyzing
the formation of hydrogen peroxide from
superoxide anion (Rahman and Adcock
2006). GSH is a major intracellular and
extracellular redox buffer and acts as a direct
free radical scavenger. In animal experiments,
supplementation with n-3 PUFA has been
shown to have a protective effect against the
toxicity of formaldehyde (FA) on the kidney.
Rats administered n-3 PUFA while exposed
to FA showed increased SOD and GSH-Px
enzyme activities and decreased levels of mal-
ondialdehyde, a marker of LPO (Zararsiz
et al. 2006). A recent study reported a
roughly linear relation between DHA in
human ﬁbroblast culture and a large increase
in intracellular GSH content contributing to
decrease in ROS levels (Arab et al. 2006).
Although in our study we measured these bio-
markers in plasma, which may not parallel
intracellular levels, their increase after supple-
mentation reflects greater protection against
oxidative stress. Long-chain n-3 PUFAs has
been shown to act both directly (e.g., by
replacing arachidonic acid as an eicosanoid
substrate and inhibiting arachidonic acid
metabolism) and indirectly by altering the
expression of inflammatory genes through
effects on transcription factor activation
(Calder 2006; Maritim et al. 2003; Valko
et al. 2006). The inverse association we
observed with LPO products suggests also
that the substitution of n-3 PUFA in the
membrane could play a role in decreasing
LPO of PUFA in the membranes.
Several factors need to be considered in
interpreting our results. Exposure assessment
was limited to a stationary 24-hr gravimetric
analysis of PM2.5 indoors; however, the diary of
daily activities kept by each participant allowed
us to assess that participants spent > 93% of
their time indoors and justify the use of indoor
PM2.5 levels to determine participants’ expo-
sure. Information about other pollutants was
available through a nearby automated monitor-
ing station, situated 3 km upwind from the
study site, allowing a reasonable estimation of
the nursing home air pollution atmosphere.
However, we did not find an association
between biomarkers of response to oxidative
stimuli and other air pollutants, and these pol-
lutants did not appear to modify the association
between PM2.5 and biomarker levels.
Our sample size limited the detailed
exploration of interactions among supple-
mentation groups and PM2.5 effect. However,
repeated measures in the same subject, with
subjects serving as their own controls (com-
paring the presupplementation and supple-
mentation phase), increased our power and
accounted for slight differences in subject
characteristics (Schouten 1999). The fact that
the sample size and the design of the study
revealed statistical evidence for an effect of
supplementation with either soy oil or ﬁsh oil
on Cu/Zn SOD and GSH, and with ﬁsh oil
on LPO, means that the power of the study
was adequate to detect these effects. The lack
of signiﬁcant effect of soy oil supplementation
on LPO could be attributable to a real lack of
effect, or to the fact that the relation of PM2.5
with LPO was weaker than with Cu/Zn SOD
and GSH, or because the potential effect of
soy oil was harder to find and therefore
would have required a larger sample size. In
addition, neither the laboratory technician
nor the participants were aware of the ran-
domization group minimizing the likelihood
of information bias.
We based compliance with the supple-
mentation on direct observation from the
medical team, because supplements were pro-
vided to the residents of the nursing home in
the morning. However, in a study conducted
in a similar population with a similar design,
Omega-3 PUFA, oxidative stress, and PM2.5
Environmental Health Perspectives • VOLUME 116 | NUMBER 9 | September 2008 1241
Figure 2. Cu/Zn SOD (A), LPO (B), and GSH (C) according to PM2.5 exposure (µg/m3; based on our GAMMs) among patients in the ﬁsh oil group. Solid line, estimated
smooth function; dashed lines, pointwise 95% CIs; circles, partial residuals. We suppressed CIs in cases where we estimated one smooth function to be linear or
any variance component to be (almost) zero, because the covariance matrix is then singular and cannot be inverted for construction of the variability bands. 
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Figure 3. Cu/Zn SOD (A), LPO (B), and GSH (C) according to PM2.5 exposure (µg/m3; based on our GAMMs) among patients in the soy oil group. Solid line, estimated
smooth function; dashed lines, pointwise 95% CIs; circles, partial residuals. We suppressed CIs in cases where we estimated one smooth function to be linear or
any variance component to be (almost) zero, because the covariance matrix is then singular and cannot be inverted for construction of the variability bands.
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cant increase of EPA, DHA, and n-3/n-6
PUFA ratio and a decrease of arachidonic acid
whereas supplementation with soy oil led to
significant increase of EPA and a marginal
increase of ALA, DHA, and n-3/n-6 PUFA
ratio in erythrocyte membranes (Romieu
et al. 2005).
A major concern with dietary supplemen-
tation is the effective dose. The fact that ﬁsh
oil appears to be more effective against oxida-
tive stress related to PM2.5 exposure than is
soy oil suggests that the small amount of
ALA—further elongated in EPA and DHA—
in soy oil might be insufficient to protect
against the adverse effects of PM2.5 exposure.
We based our results on a limited sample size
but suggest that essential fatty acids might
play an important role in modulating the
impact of PM on health, which warrants fur-
ther investigation in larger populations.
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CORRECTION
In Table 2 of the manuscript originally
published online, the intercept for LPO
was 34.54; it has been corrected here.
Romieu et al.
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